Emerging drugs for acute ischemic stroke
Department of Neurology
Acute Disease; Animals; Brain Ischemia; Clinical Trials as Topic; Fibrinolytic Agents; Hospital Units; Humans; Stroke; Thrombolytic Therapy; Treatment Outcome
Neurology | Neuroscience and Neurobiology
Stroke is no longer an untreatable condition, and its management is changing rapidly as new developments appear for acute treatments. The objective of this article is to provide a concise introduction to the pathophysiology and existing treatments for stroke, as well as discussing current research goals and interventions under evaluation, along with potential development issues. It will end with the authors' interpretations of the presented material and their opinions about where the field is going, or should go, in the coming years. The material herein is derived from current literature and expert opinion. Overall, the most important findings are that future advances in stroke treatment will probably include combination therapies that will be administered in specialized stroke care units to maximize patient outcome.
Rights and Permissions
Citation: Expert Opin Emerg Drugs. 2009 Mar;14(1):33-42. Link to article on publisher's site